JP2024505063A5 - - Google Patents
Info
- Publication number
- JP2024505063A5 JP2024505063A5 JP2023545957A JP2023545957A JP2024505063A5 JP 2024505063 A5 JP2024505063 A5 JP 2024505063A5 JP 2023545957 A JP2023545957 A JP 2023545957A JP 2023545957 A JP2023545957 A JP 2023545957A JP 2024505063 A5 JP2024505063 A5 JP 2024505063A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- crystalline
- measured
- ray diffraction
- pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163143769P | 2021-01-29 | 2021-01-29 | |
| US63/143,769 | 2021-01-29 | ||
| PCT/US2022/014261 WO2022165141A1 (en) | 2021-01-29 | 2022-01-28 | Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505063A JP2024505063A (ja) | 2024-02-02 |
| JP2024505063A5 true JP2024505063A5 (https=) | 2025-01-30 |
Family
ID=80447586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545957A Pending JP2024505063A (ja) | 2021-01-29 | 2022-01-28 | ６－（シクロプロパンカルボキサミド）－４－（（２－メトキシ－３－（１－メチル－１Ｈ－１，２，４－トリアゾール－３－イル）フェニル）アミノ）－Ｎ－（メチル－ｄ３）ピリダジン－３－カルボキサミドの結晶形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12129245B2 (https=) |
| EP (1) | EP4284796B1 (https=) |
| JP (1) | JP2024505063A (https=) |
| KR (1) | KR20230137962A (https=) |
| CN (1) | CN116829549A (https=) |
| AU (1) | AU2022214313A1 (https=) |
| CA (1) | CA3206254A1 (https=) |
| ES (1) | ES3026120T3 (https=) |
| IL (1) | IL304597A (https=) |
| MX (1) | MX2023008651A (https=) |
| WO (1) | WO2022165141A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7113023B2 (ja) * | 2017-03-30 | 2022-08-04 | ブリストル－マイヤーズ スクイブ カンパニー | ６－（シクロプロパンアミド）－４－（（２－メトキシ－３－（１－メチル－１ｈ－１，２，４－トリアゾール－３－イル）フェニル）アミノ）－ｎ－（メチル－ｄ３）ピリダジン－３－カルボキシアミドの製造方法 |
| EP4387968B1 (en) * | 2021-08-20 | 2025-11-12 | Bristol-Myers Squibb Company | Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamide |
| EP4423086A1 (en) | 2021-10-25 | 2024-09-04 | Kymera Therapeutics, Inc. | Tyk2 degraders and uses thereof |
| CN116574056A (zh) * | 2023-04-10 | 2023-08-11 | 五邑大学 | 一种氟代异喹啉酮类化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3495358T (lt) * | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| JP7113023B2 (ja) * | 2017-03-30 | 2022-08-04 | ブリストル－マイヤーズ スクイブ カンパニー | ６－（シクロプロパンアミド）－４－（（２－メトキシ－３－（１－メチル－１ｈ－１，２，４－トリアゾール－３－イル）フェニル）アミノ）－ｎ－（メチル－ｄ３）ピリダジン－３－カルボキシアミドの製造方法 |
| KR102848769B1 (ko) * | 2018-05-31 | 2025-08-20 | 브리스톨-마이어스 스큅 컴퍼니 | 6-(시클로프로판카르복스아미도)-4-((2-메톡시-3-(1-메틸-1h-1,2,4-트리아졸-3-일)페닐)아미노)-n-(메틸-d3) 피리다진-3-카르복스아미드의 결정질 형태 |
| US12570637B2 (en) * | 2019-06-12 | 2026-03-10 | Bristol-Myers Squibb Company | Crystalline salt forms 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyld3) pyridazine-3-carboxamide |
-
2022
- 2022-01-28 KR KR1020237028773A patent/KR20230137962A/ko active Pending
- 2022-01-28 CA CA3206254A patent/CA3206254A1/en active Pending
- 2022-01-28 AU AU2022214313A patent/AU2022214313A1/en active Pending
- 2022-01-28 JP JP2023545957A patent/JP2024505063A/ja active Pending
- 2022-01-28 MX MX2023008651A patent/MX2023008651A/es unknown
- 2022-01-28 WO PCT/US2022/014261 patent/WO2022165141A1/en not_active Ceased
- 2022-01-28 US US17/587,374 patent/US12129245B2/en active Active
- 2022-01-28 ES ES22704232T patent/ES3026120T3/es active Active
- 2022-01-28 CN CN202280012179.5A patent/CN116829549A/zh active Pending
- 2022-01-28 EP EP22704232.2A patent/EP4284796B1/en active Active
-
2023
- 2023-07-19 IL IL304597A patent/IL304597A/en unknown
-
2024
- 2024-09-24 US US18/895,353 patent/US20250154132A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024505063A5 (https=) | ||
| JP6966590B2 (ja) | オメカムチブメカルビルの塩及び塩を調製するプロセス | |
| JP4624667B2 (ja) | １−４−（５−シアノインドール−３−イル）ブチル−４−（２−カルバモイルベンゾフラン−５−イル）ピペラジン塩酸塩の多形相 | |
| JP2024514090A5 (https=) | ||
| JP2023036708A5 (https=) | ||
| JP2012527442A5 (https=) | ||
| JP2022551316A5 (https=) | ||
| JP3665053B2 (ja) | 純結晶形態の５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニルおよび合成方法 | |
| JP2024521412A5 (https=) | ||
| ZA200106371B (en) | 3-Phenylpyridine derivatives and their use as NK-1 receptor antagonist. | |
| JP2024540922A5 (https=) | ||
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| CA2505361A1 (en) | Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist | |
| JP2015516968A5 (https=) | ||
| JP2022533340A5 (https=) | ||
| JP2009521414A5 (https=) | ||
| AU2001264804A1 (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis | |
| JP2024547113A5 (https=) | ||
| JP2024529763A5 (https=) | ||
| CN115819257A (zh) | 维兰特罗三苯乙酸盐的新结晶形式及其制备方法 | |
| JP2018522945A5 (https=) | ||
| KR20180036722A (ko) | 빌라스틴의 결정형 및 그의 제조 방법 | |
| CN111793074B (zh) | K-5a2化合物的晶型及其制备方法和应用 | |
| JP2023521411A5 (https=) | ||
| JP2025508792A5 (https=) |